HOMEPostContact Us
Posted May 16. 2013 1:50PM

Manchester-based Boston Therapeutics posts wider net loss for quarter

Click headline or here to open angled item
The Company had a net loss of $667,422, or ($0.04) per share, for the quarter ended March 31, 2013 compared with a net loss of $257,405 or ($0.02) for the same period in the prior year. The Company's cash balance at March 31, 2013 was $384,674.